Final-Program-ATS-2023-AP.vp

288

TUESDAY • MAY 23

Chairing: S.C. Mathai, MD, MHS, Baltimore, MD

• to ascertain the clinical phenotype of long COVID-19 in kids and adults and review the latest research on pathogenicity Despite very early assumptions, children are not spared from COVID-19. However, biological and clinical responses vary considerably across the age spectrum. In this session, we will assess biologic responses to SARS-CoV-2, which will serve as a foundation for comparisons with other common respiratory viruses. We will discuss the passive transfer of maternal antibodies to infants and their clinical protection; airway signals in the upper airway in response to infection in children as compared to adults; hematologic biomarkers of severe infection in children and adults infected with SARS-CoV-2; and clinical and molecular findings in long COVID-19. Chairing: L. Yonker, MD, Boston, MA M.A. Mall, MD, Berlin, Germany 2:15 Passive Immunity in Neonates A. Edlow, MD, MSc, Boston, MA 2:35 Airway Responses to SARS-CoV-2 M.A. Mall, MD, Berlin, Germany 2:55 Hematologic Markers of Severe COVID-19 and MISC O. Badaki-Makun, MD CM, PhD, Baltimore, MD 3:15 Long COVID-19 S.A. Mcgrath-Morrow, MD, Philadelphia, PA 3:35 Tying it Together L. Yonker, MD, Boston, MA BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 1.5 ACHIEVING HEALTH EQUITY: REDUCING THE IMPACT OF SDOH THROUGH RESEARCH AND ADVOCACY Assemblies on Behavioral Science and Health Services Research; Nursing; Pediatrics; Sleep and Respiratory Neurobiology; Health Equity and Diversity Committee; Health Policy Committee; International Health Committee 2:15 PM - 3:45 PM Walter E. Washington Convention Center Room 145 A-B (Street Level) Target Audience Interprofessional healthcare providers including clinicians, health system administrators, researchers focused on health care delivery science Objectives At the conclusion of this session, the participant will be able to: • increase incorporation of SDOH in current clinical and translational research C89

C.E. Ventetuolo, MD, MSCR, Providence, RI

2:15 Patient Speaker

Speaker To Be Announced 2:20 The Emperor Has No Clothes: Current Outcome Measures in PH S.C. Mathai, MD, MHS, Baltimore, MD 2:35 Patient Reported Outcomes: The Missing Piece in Assessment of PH Outcomes H.M. Dubrock, MD, Rochester, MN 2:55 Walking in Circles: Functional Assessment as an Outcome Measure in PH J. Minhas, MD, MS, MBBS, Philadelphia, PA 3:15 Risk Scores and Survival as Outcome Measures in PH S.M. Kawut, MD, MS, ATSF, Philadelphia, PA 3:35 Panel Discussion This session and the International Conference are supported by an I ndependent medical educational grant from Merck & Co., and United Therapeutics Corporation. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

BASIC • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM

CME Credits Available: 1.5 MOC Points Available: 1.5

C88

BIOLOGICAL IMPACT OF COVID-19 ACROSS THE LIFESPAN

Assemblies on Pediatrics; Allergy, Immunology and Inflammation; Pulmonary Infections and Tuberculosis; Respiratory Cell and Molecular Biology 2:15 PM - 3:45 PM Target Audience Pediatric pulmonologists, adult pulmonologists, and basic and translational researchers Objectives At the conclusion of this session, the participant will be able to: • to better understand the role and durability of passive immunity against COVID-19 and other infections in newborns • understand immune responses in the airway in in circulation in response to acute SARS-CoV-2 infection Marriott Marquis Washington Marquis Ballroom Salon 5 (Level M2)

ATS 2023 • Washington, DC